Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia

被引:22
作者
Brennan, Stephen O. [1 ,2 ]
Mangos, Hilda [3 ]
Faed, James M. [3 ,4 ]
机构
[1] Univ Otago, Dept Pathol, Mol Pathol Lab, Christchurch, New Zealand
[2] Canterbury Hlth Labs, Christchurch 8014, New Zealand
[3] Dunedin Publ Hosp, Oncol Haematol Dept, Dunedin, New Zealand
[4] Univ Otago, Dept Pathol, Dunedin, New Zealand
关键词
Fibrinogen; fibrin; gene mutations; gene expression; inherited coagulation disorders; time of flight MS; HUMAN-FIBRINOGEN; GAMMA-CHAIN; SUBSTITUTION; BETA;
D O I
10.1160/TH13-08-0657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a novel procedure for the direct analysis of plasma fibrinogen by HPLC time of flight (TOF) mass spectrometry and apply it to the investigation of a family with hypofibrinogenaemia. Electrospray TOF analysis provided much higher resolution than was possible with our previous quadrupole analyser and revealed three different mass changes within the fibrinogen 136 and gamma chains of the family. It also demonstrated the actual hypofibrinogenaemia phenotype was caused, by an aberrant gamma chain (-23 Da) which was expressed at a diminished ratio of 0.2:1 relative to gamma(A) and co-inherited with a second coequally expressed BP variant (B beta(M) /[B beta(A), 1:1). Co-segregation was confirmed by gene analysis that showed the affected father and son had a very rare B beta 148Lys -> Arg mutation (-14 Da) inherited together with a unique new gamma 211Tyr -> His mutation (-26 Da). This latter causative substitution occurs at a site that is absolutely conserved across all fibrinogen chains and preserved across all species. TOF analysis also identified a variant B beta chain (54,186 Da) that was coequally expressed with normal B beta chains (54,213 Da) in the unaffected mother.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 18 条
[1]  
Brennan SO, 2005, THROMB HAEMOSTASIS, V93, P1196
[2]   Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 val->Asp) [J].
Brennan, SO ;
Hammonds, B ;
George, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2854-2858
[3]   Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted) [J].
Brennan, Stephen O. ;
Chitlur, Meera .
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (06) :1180-1182
[4]   Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content [J].
Brennan, Stephen O. ;
Davis, Ryan L. .
THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) :1274-1276
[5]   Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia [J].
Brennan, Stephen O. ;
Davis, Ryan L. ;
Conard, Katrina ;
Savo, Anthony ;
Furuya, Katryn N. .
LIVER INTERNATIONAL, 2010, 30 (10) :1541-1547
[6]  
Davis RL, 2007, HAEMATOLOGICA, V94, P1151
[7]   A Deep Intronic Mutation in FGB Creates a Consensus Exonic Splicing Enhancer Motif That Results in Afibrinogenemia Caused by Aberrant mRNA Splicing, Which Can Be Corrected In Vitro With Antisense Oligonucleotide Treatment [J].
Davis, Ryan L. ;
Homer, Vivienne M. ;
George, Peter M. ;
Brennan, Stephen O. .
HUMAN MUTATION, 2009, 30 (02) :221-227
[8]   Four cases of hypofibrinogenemia associated with four novel mutations [J].
Hanss, M ;
Ffrench, P ;
Vinciguerra, C ;
Bertrand, MA ;
de Mazancourt, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) :2347-2349
[9]  
Hanss M, 2001, ANN NY ACAD SCI, V936, P89
[10]  
HAVERKATE F, 1995, THROMB HAEMOSTASIS, V73, P151